Increase of Release | Inhibition of Release | |||
---|---|---|---|---|
Via Autoreceptors | Via Heteroreceptors | Via Autoreceptors | Via Heteroreceptors | |
Glutamatergic (Glu) | AMPA,4 NMDA,46 KA49 | nAChR (α7),17 P2X,34 A2A,36GABAA 53 | mGluR4/7/8 (EP),6KA5 | GABAB,15 M2 (EP),18A1,48 α2 52 |
GABAergic (GABA) | D1,3 nAChR (α7 or α4β2, EP),1 5 HT3(EP)21 | GABAB 10 | mGluR2/3 (EP),19KA,16 M2,26 D2,32 5HT1A(EP),20 A2A (EP)51 | |
Cholinergic (ACh) | nAChR9 | A2A,37P2X38 | M2,8 M47 | 5-HT1B,22A1 (EP),35 D2,42 A1 43 |
Noradrenergic (NE) | α1 11 | NMDA23/AMPA/KA,24nAChR(α3β2),2 GABAA,25 P2X,405-HT3 57 | α2A 12 | GABAB,25P2Y,39 A1 50 |
Serotonergic (5-HT) | 5-HT3 55 | AMPA27 | 5-HT1B/D,13,145-HT1D 54 | α2A,30GABAA,28 GABAB,29 M131 |
Dopaminergic (DA) | P2X,41 non-NMDA,44 nAChR (α4β2,45 α3β247), 5-HT3 56 | D2 33 |
1 (α7, EP) Alkondon et al., 1996, 1997. (α4β2, EP)Lu et al., 1998; Lena and Changeux, 1997.
2 (α3β2) Vizi et al., 1995; Sershen et al., 1997.
3 (D1) Floran et al., 1990.
4 (AMPA) Barnes et al., 1994; Chaki et al., 1998.
5 (KA) Chittajallu et al., 1996.
6 [mGluR4/7/8 (EP)] Scanziani et al., 1997.
7 (M4) McKinney et al., 1993.
8 (M2) Richards, 1990.
9 (nAChR) Wilkie et al., 1996.
10 (GABAB) Pittaluga et al., 1987.
11 (α1) Pastor et al., 1996.
12 (α2A) Kiss et al., 1995; and see Table 3.
13 (5-HT1B/D) Maura et al., 1986.
14 (5-HT1B/D) Limberger et al., 1991; Jackisch et al., 1999a.
15 (GABAB) Pende et al., 1993.
16 (KA) Cunha et al., 1997.
17 (α7) Gray et al., 1996.
18 (M2) Marchi and Raiteri, 1989; (EP) Hasselmo and Bower, 1992.
19 [mGluR2/3 (EP)] Poncer et al., 1995.
20 [5-HT1A (EP)] Bijak and Misgeld, 1997.
21 [5-HT3 (EP)] Peters et al., 1992; Piguet and Galvan, 1994.
22 (5-HT1B) Maura and Raiteri, 1986.
23 (NMDA) Pittaluga and Raiteri, 1990.
24 (AMPA/KA) Pittaluga and Raiteri, 1992a; Desai et al., 1994,1995; Patel and Croucher, 1997; Cowen and Beart, 1998.
25 (GABAB) Fung and Fillenz, 1983.
26 (M2) Raiteri et al., 1990b; (EP) Levey et al., 1995.
27 (AMPA) Pittaluga et al., 1997.
28 (GABAA) Balfour, 1980.
29 (GABAB) Andrews et al., 1992.
30 (α2A) Gobbi et al., 1990; MacDonald et al., 1997.
31 (M1) Marchi et al., 1986.
32 (D2) Floran et al., 1997; Hársing and Zigmond, 1997.
33 (D2) Hoffmann and Cubeddu, 1984.
34 (P2X) Gu and MacDermott, 1997.
35 (A1) Morton and Davies, 1997.
36 (A2A) Popoli et al., 1995.
37 (A2A) Cunha et al., 1994, 1995; Brown et al., 1990.
38 (P2X) Sperlágh and Vizi, 1991; Sun and Stanley, 1996.
39 (P2Y) von Kugelgen et al., 1994; Koch et al., 1997.
40 (P2X) Boehm, 1999.
41 (P2X) Zhang et al., 1996.
42 (D2) Hoffmann and Cubeddu, 1984.
43 (D2) Cunha et al., 1994; Jackisch et al., 1984.
44 (non-NMDA) Petitet et al., 1995.
45 (nAChR, α4β2) Grady et al., 1994.
46 (NMDA) Montague et al., 1994 (via NO production).
47 (nAChR, α3β2) Kulak et al., 1997.
48 (A1) Corradetti et al., 1984; Fastbom and Fredholm, 1985.
49 (KA) Terrian et al., 1991; Malva et al., 1996.
50 (A1) Harms et al., 1978; von Kügelgen et al., 1992.
51 (A2A) Kirk and Richardson, 1994; (EP) Mori et al., 1996.
52 (α2) Kamisaki et al., 1992; Bickler and Hansen, 1996.
53 (GABAA) Herrero et al., 1999.
54 (5-HT1D) Galzin et al., 1992 (human); Maura et al., 1993 (human).
55 (5-HT3) Martin et al., 1992; Bagdy et al., 1998.
56 (5-HT3) Zazpe et al., 1994.
57 (5-HT3) Allgaier et al., 1995.